Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease

Neuropharmacology

Volumn 116, Issue , 2017, Pages 82-97

  Caioli, Silvia ^a   Severini, Cinzia ^b   Ciotti, Teresa ^c   Florenzano, Fulvio ^c   Pimpinella, Domenico ^a   Petrocchi Passeri, Pamela ^b   Balboni, Gianfranco ^d   Polisca, Patrizio ^e   Lattanzi, Roberta ^f   Nisticò, Robert ^c,e   Negri, Lucia ^f   Zona, Cristina ^a,e  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b CNR   (Italy)

^c EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Amyloid beta; Electrophysiology; Glutamatergic neurotransmission; Prokineticin system

Indexed keywords

AMPA RECEPTOR; AMYLOID BETA PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR; KAINIC ACID; PROKINETICIN 2; PROKINETICIN 2 RECEPTOR; PROTEIN KINASE C; UNCLASSIFIED DRUG; 2-(1-(3-DIMETHYLAMINOPROPYL)-5-METHOXYINDOL-3-YL)-3-(1H-INDOL-3-YL)MALEIMIDE; AMPHIBIAN PROTEIN; BV8 PROTEIN, BOMBINA VARIEGATA; G PROTEIN COUPLED RECEPTOR; GASTROINTESTINAL HORMONE; GLUTAMIC ACID; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; NEUROPEPTIDE; NEUROPROTECTIVE AGENT; PROKR2 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN ELECTROPHYSIOLOGY; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; EXPOSURE; FEMALE; GLUTAMATERGIC TRANSMISSION; IMMUNOFLUORESCENCE; ION CURRENT; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; ANURA; BRAIN CORTEX; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION; WISTAR RAT;

ALZHEIMER DISEASE; AMPHIBIAN PROTEINS; AMYLOID BETA-PEPTIDES; ANIMALS; ANURA; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; GASTROINTESTINAL HORMONES; GLUTAMIC ACID; INDOLES; MALEIMIDES; NEURONS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; SYNAPTIC TRANSMISSION;

EID: 85008235642     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2016.12.012     Document Type: Article

References (90)

1. Akiyama, H., Arai, T., Kondo, H., Tanno, E., Haga, C., Ikeda, K., Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. Assoc. Disord. 14:Suppl. 1 (2000), S47–S53.
2. Alberdi, E., Sanchez-Gomez, M.V., Cavaliere, F., Perez-Samartin, A., Zugaza, J.L., Trullas, R., Domercq, M., Matute, C., Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium 47 (2010), 264–272.
3. Balboni, G., Lazzari, I., Trapella, C., Negri, L., Lattanzi, R., Giannini, E., Nicotra, A., Melchiorri, P., Visentin, S., Nuccio, C.D., Salvadori, S., Triazine compounds as antagonists at Bv8-prokineticin receptors. J. Med. Chem. 51 (2008), 7635–7639.
4. Banke, T.G., Bowie, D., Lee, H., Huganir, R.L., Schousboe, A., Traynelis, S.F., Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J. Neurosci. 20 (2000), 89–102.
5. Baron, P., Bussini, S., Cardin, V., Corbo, M., Conti, G., Galimberti, D., Scarpini, E., Bresolin, N., Wharton, S.B., Shaw, P.J., Silani, V., Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 32 (2005), 541–544.
6. Barria, A., Muller, D., Derkach, V., Griffith, L.C., Soderling, T.R., Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Sci. (New York, N. Y. ) 276 (1997), 2042–2045.
7. Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., Berger, M., Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285 (1991), 111–114.
8. Belkouch, M., Dansereau, M.A., Reaux-Le Goazigo, A., Van Steenwinckel, J., Beaudet, N., Chraibi, A., Melik-Parsadaniantz, S., Sarret, P., The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a Gbetagamma-dependent mechanism. J. Neurosci. 31 (2011), 18381–18390.
9. Ben Achour, S., Pascual, O., Glia: the many ways to modulate synaptic plasticity. Neurochem. Int. 57 (2010), 440–445.
10. Blanchard, B.J., Chen, A., Rozeboom, L.M., Stafford, K.A., Weigele, P., Ingram, V.M., Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 14326–14332.
11. Boehm, J., Kang, M.-G., Johnson, R.C., Esteban, J., Huganir, R.L., Malinow, R., Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1. Neuron 51 (2006), 213–225.
12. Busche, M.A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.H., Haass, C., Staufenbiel, M., Konnerth, A., Garaschuk, O., Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 321 (2008), 1686–1689.
13. Cacquevel, M., Lebeurrier, N., Cheenne, S., Vivien, D., Cytokines in neuroinflammation and Alzheimer's disease. Curr. Drug Targets 5 (2004), 529–534.
14. Cagnin, A., Brooks, D.J., Kennedy, A.M., Gunn, R.N., Myers, R., Turkheimer, F.E., Jones, T., Banati, R.B., In-vivo measurement of activated microglia in dementia. Lancet 358 (2001), 461–467.
15. Caioli, S., Curcio, L., Pieri, M., Antonini, A., Marolda, R., Severini, C., Zona, C., Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis. Neurobiol. Dis. 44 (2011), 92–101.
16. Caioli, S., Pieri, M., Antonini, A., Guglielmotti, A., Severini, C., Zona, C., Monocyte Chemoattractant Protein-1 upregulates GABA-induced current: evidence of modified GABAA subunit composition in cortical neurons from the G93A mouse model of Amyotrophic Lateral Sclerosis. Neuropharmacology 73 (2013), 247–260.
17. Cheng, M.Y., Leslie, F.M., Zhou, Q.Y., Expression of prokineticins and their receptors in the adult mouse brain. J. Comp. Neurol. 498 (2006), 796–809.
18. Cheng, M.Y., Lee, A.G., Culbertson, C., Sun, G., Talati, R.K., Manley, N.C., Li, X., Zhao, H., Lyons, D.M., Zhou, Q.Y., Steinberg, G.K., Sapolsky, R.M., Prokineticin 2 is an endangering mediator of cerebral ischemic injury. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 5475–5480.
19. Cottrell, G.T., Zhou, Q.Y., Ferguson, A.V., Prokineticin 2 modulates the excitability of subfornical organ neurons. J. Neurosci. 24 (2004), 2375–2379.
20. Crews, L., Rockenstein, E., Masliah, E., APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis. Brain Struct. Funct. 214 (2010), 111–126.
21. Derkach, V., Barria, A., Soderling, T.R., Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 3269–3274.
22. Dias, R.B., Ribeiro, J.A., Sebastiao, A.M., Enhancement of AMPA currents and GluR1 membrane expression through PKA-coupled adenosine A(2A) receptors. Hippocampus 22 (2012), 276–291.
23. Diering, G.H., Heo, S., Hussain, N.K., Liu, B., Huganir, R.L., Extensive phosphorylation of AMPA receptors in neurons. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E4920–E4927.
24. Dorsch, M., Qiu, Y., Soler, D., Frank, N., Duong, T., Goodearl, A., O'Neil, S., Lora, J., Fraser, C.C., PK1/EG-VEGF induces monocyte differentiation and activation. J. Leukoc. Biol. 78 (2005), 426–434.
25. De Felice, F.G., Velasco, P.T., Lambert, M.P., Viola, K., Fernandez, S.J., Ferreira, S.T., Klein, W.L., Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282 (2007), 11590–11601.
26. Finch, C.E., Morgan, T.E., Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. Curr. Alzheimer Res. 4 (2007), 185–189.
27. Giannini, E., Lattanzi, R., Nicotra, A., Campese, A.F., Grazioli, P., Screpanti, I., Balboni, G., Salvadori, S., Sacerdote, P., Negri, L., The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 14646–14651.
28. Gu, Z., Liu, W., Yan, Z., {beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution. J. Biol. Chem. 284 (2009), 10639–10649.
29. Haass, C., Selkoe, D.J., Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8 (2007), 101–112.
30. Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002), 353–356.
31. Hatton, C.J., Shelley, C., Brydson, M., Beeson, D., Colquhoun, D., Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits. J. Physiol. 547 (2003), 729–760.
32. Hayashi, T., Huganir, R.L., Tyrosine phosphorylation and regulation of the AMPA receptor by SRC family tyrosine kinases. J. Neurosci. 24 (2004), 6152–6160.
33. He, K., Song, L., Cummings, L.W., Goldman, J., Huganir, R.L., Lee, H.K., Stabilization of Ca2+-permeable AMPA receptors at perisynaptic sites by GluR1-S845 phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 20033–20038.
34. Heneka, M.T., O'Banion, M.K., Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184 (2007), 69–91.
35. Henkel, J.S., Beers, D.R., Siklos, L., Appel, S.H., The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol. Cell Neurosci. 31 (2006), 427–437.
36. Hoozemans, J.J., Veerhuis, R., Rozemuller, J.M., Eikelenboom, P., Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology. CNS Neurol. Disord. Drug Targets 10 (2014), 57–67.
37. Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., Malinow, R., AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52 (2006), 831–843.
38. Huang, Y., Mucke, L., Alzheimer mechanisms and therapeutic strategies. Cell 148 (2012), 1204–1222.
39. Incontro, S., Ciruela, F., Ziff, E., Hofmann, F., Sanchez-Prieto, J., Torres, M., The type II cGMP dependent protein kinase regulates GluA1 levels at the plasma membrane of developing cerebellar granule cells. Biochim. Biophys. Acta 1833 (2013), 1820–1831.
40. Ingves, M.V., Ferguson, A.V., Prokineticin 2 modulates the excitability of area postrema neurons in vitro in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298 (2010), R617–R626.
41. Jenkins, M.A., Traynelis, S.F., PKC phosphorylates GluA1-Ser831 to enhance AMPA receptor conductance. Channels (Austin) 6 (2012), 60–64.
42. Kelly, B.L., Ferreira, A., beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J. Biol. Chem. 281 (2006), 28079–28089.
43. Klein, A.N., Ziehm, T., Tusche, M., Buitenhuis, J., Bartnik, D., Boeddrich, A., Wiglenda, T., Wanker, E., Funke, S.A., Brener, O., Gremer, L., Kutzsche, J., Willbold, D., Optimization of the all-d peptide D3 for abeta oligomer elimination. PLoS One, 11, 2013, e0153035.
44. Kristensen, A.S., Jenkins, M.A., Banke, T.G., Schousboe, A., Makino, Y., Johnson, R.C., Huganir, R., Traynelis, S.F., Mechanism of Ca2+/calmodulin-dependent kinase II regulation of AMPA receptor gating. Nat. Neurosci. 14 (2011), 727–735.
45. Landucci, E., Lattanzi, R., Gerace, E., Scartabelli, T., Balboni, G., Negri, L., Pellegrini-Giampietro, D.E., Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro. Neuropharmacology 108 (2016), 39–48.
46. Lattanzi, R., Maftei, D., Marconi, V., Florenzano, F., Franchi, S., Borsani, E., Rodella, L.F., Balboni, G., Salvadori, S., Sacerdote, P., Negri, L., Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model. Biomed. Res. Int., 2015, 2015, 301292.
47. LeCouter, J., Zlot, C., Tejada, M., Peale, F., Ferrara, N., Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 16813–16818.
48. Lee, H.K., Synaptic plasticity and phosphorylation. Pharmacol. Ther. 112 (2006), 810–832.
49. Lee, H.-K., Takamiya, K., Han, J.-S., Man, H., Kim, C.-H., Rumbaugh, G., Yu, S., Ding, L., He, C., Petralia, R.S., Wenthold, R.J., Gallagher, M., Huganir, R.L., Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory. Cell 112 (2003), 631–643.
50. Li, S., Jin, M., Koeglsperger, T., Shepardson, N.E., Shankar, G.M., Selkoe, D.J., Soluble Abeta oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J. Neurosci. 31 (2011), 6627–6638.
51. Lu, W., Roche, K.W., Posttranslational regulation of AMPA receptor trafficking and function. Curr. Opin. Neurobiol. 22 (2012), 470–479.
52. Maftei, D., Marconi, V., Florenzano, F., Giancotti, L.A., Castelli, M., Moretti, S., Borsani, E., Rodella, L.F., Balboni, G., Luongo, L., Maione, S., Sacerdote, P., Negri, L., Lattanzi, R., Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals. Br. J. Pharmacol. 171 (2014), 4850–4865.
53. Mao, L.M., Tang, Q., Wang, J.Q., Protein kinase C-regulated cAMP response element-binding protein phosphorylation in cultured rat striatal neurons. Brain Res. Bull. 72 (2007), 302–308.
54. Mao, L.M., Guo, M.L., Jin, D.Z., Fibuch, E.E., Choe, E.S., Wang, J.Q., Post-translational modification biology of glutamate receptors and drug addiction. Front. Neuroanat., 5, 2011, 19.
55. Meda, L., Baron, P., Scarlato, G., Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins. Neurobiol. Aging 22 (2001), 885–893.
56. Melchiorri, D., Bruno, V., Besong, G., Ngomba, R.T., Cuomo, L., De Blasi, A., Copani, A., Moschella, C., Storto, M., Nicoletti, F., Lepperdinger, G., Passarelli, F., The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways. Eur. J. Neurosci. 13 (2001), 1694–1702.
57. Mines, M., Ding, Y., Fan, G.H., The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategies. Curr. Med. Chem. 14 (2007), 2456–2470.
58. Mollay, C., Wechselberger, C., Mignogna, G., Negri, L., Melchiorri, P., Barra, D., Kreil, G., Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur. J. Pharmacol. 374 (1999), 189–196.
59. Morioka, N., Yoshida, Y., Nakamura, Y., Hidaka, N., Hisaoka-Nakashima, K., Nakata, Y., The regulation of exon-specific brain-derived neurotrophic factor mRNA expression by protein kinase C in rat cultured dorsal root ganglion neurons. Brain Res. 1509 (2013), 20–31.
60. Mrak, R.E., Griffin, W.S., Potential inflammatory biomarkers in Alzheimer's disease. J. Alzheimers Dis. 8 (2005), 369–375.
61. Mrak, R.E., Griffin, W.S., Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26 (2005), 349–354.
62. Negri, L., Lattanzi, R., Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system. Curr. Opin. Pharmacol. 12 (2012), 62–66.
63. Negri, L., Lattanzi, R., Giannini, E., Colucci, M.A., Mignogna, G., Barra, D., Grohovaz, F., Codazzi, F., Kaiser, A., Kreil, G., Melchiorri, P., Biological activities of Bv8 analogues. Br. J. Pharmacol. 146 (2005), 625–632.
64. Negri, L., Lattanzi, R., Giannini, E., Melchiorri, P., Bv8/Prokineticin proteins and their receptors. Life Sci. 81 (2007), 1103–1116.
65. Negri, L., Lattanzi, R., Giannini, E., Canestrelli, M., Nicotra, A., Melchiorri, P., Bv8/Prokineticins and their receptors a new pronociceptive system. Int. Rev. Neurobiol. 85 (2009), 145–157.
66. Neher, E., Sakmann, B., The patch clamp technique. Sci. Am. 266 (1992), 44–51.
67. Nimmrich, V., Grimm, C., Draguhn, A., Barghorn, S., Lehmann, A., Schoemaker, H., Hillen, H., Gross, G., Ebert, U., Bruehl, C., Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J. Neurosci. 28 (2008), 788–797.
68. Orlandi, C., La Via, L., Bonini, D., Mora, C., Russo, I., Barbon, A., Barlati, S., AMPA receptor regulation at the mRNA and protein level in rat primary cortical cultures. PLoS One, 6, 2011, e25350.
69. Palop, J.J., Mucke, L., Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 13 (2010), 812–818.
70. Parameshwaran, K., Dhanasekaran, M., Suppiramaniam, V., Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp. Neurol. 210 (2008), 7–13.
71. Perez, Y., Ratte, S., Sanon, N., Lapointe, V., Lacaille, J.C., Cell type-specific changes in spontaneous and minimally evoked excitatory synaptic activity in hippocampal CA1 interneurons of kainate-treated rats. Epilepsy Res. 68 (2006), 241–254.
72. Ren, P., Zhang, H., Qiu, F., Liu, Y.Q., Gu, H., O'Dowd, D.K., Zhou, Q.Y., Hu, W.P., Prokineticin 2 regulates the electrical activity of rat suprachiasmatic nuclei neurons. PLoS One, 6, 2011, e20263.
73. Roche, K.W., O'Brien, R.J., Mammen, A.L., Bernhardt, J., Huganir, R.L., Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16 (1996), 1179–1188.
74. Rubio-Perez, J.M., Morillas-Ruiz, J.M., A review: inflammatory process in Alzheimer's disease, role of cytokines. Sci. World J., 2012, 2012, 756357.
75. Sanz-Clemente, A., Gray, J.A., Ogilvie, K.A., Nicoll, R.A., Roche, K.W., Activated CaMKII couples GluN2B and casein kinase 2 to control synaptic NMDA receptors. Cell Rep. 3 (2013), 607–614.
76. Seidenman, K.J., Steinberg, J.P., Huganir, R., Malinow, R., Glutamate receptor subunit 2 Serine 880 phosphorylation modulates synaptic transmission and mediates plasticity in CA1 pyramidal cells. J. Neurosci. 23 (2003), 9220–9228.
77. Selkoe, D.J., Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001), 741–766.
78. Selkoe, D.J., Alzheimer's disease is a synaptic failure. Science 298 (2002), 789–791.
79. Selvakumar, B., Jenkins, M.A., Hussain, N.K., Huganir, R.L., Traynelis, S.F., Snyder, S.H., S-nitrosylation of AMPA receptor GluA1 regulates phosphorylation, single-channel conductance, and endocytosis. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 1077–1082.
80. Severini, C., Passeri, P.P., Ciotti, M., Florenzano, F., Possenti, R., Zona, C., Di Matteo, A., Guglielmotti, A., Calissano, P., Pachter, J., Mercanti, D., Bindarit, inhibitor of CCL2 synthesis, protects neurons against amyloid-beta-induced toxicity. J. Alzheimers Dis. 38 (2013), 281–293.
81. Severini, C., Lattanzi, R., Maftei, D., Marconi, V., Ciotti, M.T., Petrocchi Passeri, P., Florenzano, F., Del Duca, E., Caioli, S., Zona, C., Balboni, G., Salvadori, S., Nistico, R., Negri, L., Bv8/prokineticin 2 is involved in Abeta-induced neurotoxicity. Sci. Rep., 5, 2015, 15301.
82. Shankar, G.M., Li, S., Mehta, T.H., Garcia-Munoz, A., Shepardson, N.E., Smith, I., Brett, F.M., Farrell, M.A., Rowan, M.J., Lemere, C.A., Regan, C.M., Walsh, D.M., Sabatini, B.L., Selkoe, D.J., Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14 (2008), 837–842.
83. Soga, T., Matsumoto, S., Oda, T., Saito, T., Hiyama, H., Takasaki, J., Kamohara, M., Ohishi, T., Matsushime, H., Furuichi, K., Molecular cloning and characterization of prokineticin receptors. Biochim. Biophys. Acta 1579 (2002), 173–179.
84. Szegedi, V., Juhasz, G., Budai, D., Penke, B., Divergent effects of Abeta1–42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo. Brain Res. 1062 (2005), 120–126.
85. Urayama, K., Guilini, C., Turkeri, G., Takir, S., Kurose, H., Messaddeq, N., Dierich, A., Nebigil, C.G., Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation. Arterioscler. Thromb. Vasc. Biol. 28 (2008), 841–849.
86. Vellani, V., Colucci, M., Lattanzi, R., Giannini, E., Negri, L., Melchiorri, P., McNaughton, P.A., Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8. J. Neurosci.: off. J. Soc. Neurosci. 26 (2006), 5109–5116.
87. Wang, D., Govindaiah, G., Liu, R., De Arcangelis, V., Cox, C.L., Xiang, Y.K., Binding of amyloid beta peptide to beta2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity. Faseb J. 24 (2010), 3511–3521.
88. Wyss-Coray, T., Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 12 (2006), 1005–1015.
89. Ye, C., Walsh, D.M., Selkoe, D.J., Hartley, D.M., Amyloid beta-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-D-aspartate (NMDA) versus non-NMDA receptor/channel activation. Neurosci. Lett. 366 (2004), 320–325.
90. Yuill, E.A., Hoyda, T.D., Ferri, C.C., Zhou, Q.Y., Ferguson, A.V., Prokineticin 2 depolarizes paraventricular nucleus magnocellular and parvocellular neurons. Eur. J. Neurosci. 25 (2007), 425–434.